Yu, X., Liu, J., Qiu, H., Hao, H., Zhu, J. and Peng, S. (2021) “Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer”, Biomolecules and Biomedicine, 21(2), pp. 198–207. doi: 10.17305/bjbms.2020.4746.